高龄人群血清促甲状腺激素、血脂水平与年龄的相关性分析被引量：4

A relativity analysis on the thyroid stimulating hormone,blood lipid and age level in the aged population

导出

摘要促甲状腺激素（Thyroid stimulating hormone,TSH）是一类促进甲状腺生长并维持其生理功能的重要激素,在调节物质和能量代谢方面发挥重要作用。近年来,亚临床甲状腺功能减退（Subclinical hypothyroidism,SCH）在高龄人群中高发,其是一种以血清TSH分泌量明显升高而甲状腺功能正常为主要临床症状的内分泌代谢性疾病。 In this study,we analysis the relationship of the thyroid stimulating hormone,blood lipid and age level in the aged population.From March 2010 to March 2014,a total of 236 elderly patients from the medical examination center and hospitalization of our hospital were studied.The thyroid function and blood lipid were analyzed retrospectively.Result showed that TSH,TG,TC and LDL-C increased with aging.The result of Pearson＇s correlation analysis showed that there was a positive correlation among TSH and TG,TC and LDL-C（r=0.281,0.548,0.332,P〈0.05）.

作者张秀云

机构地区宁夏回族自治区宁东医院妇产科

出处《临床心血管病杂志》 CAS CSCD 北大核心 2016年第4期421-423,共3页 Journal of Clinical Cardiology

关键词高龄年龄促甲状腺激素血脂水平 aged population age thyroid stimulating hormone blood lipid

分类号 R544.1 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1吴娟,林奉森,乔玉芳,朱香清,陈兆樵,林丽香,陈刚.福建省畲族人群单根据TSH水平来评定甲状腺功能异常患病率的调查[J].中华内分泌代谢杂志,2013,29(11):968-970. 被引量：3
2黄波,刘芳,刘梅林,杜佳丽,王禹川.单中心老年心血管病危险因素控制现状分析[J].中华老年心脑血管病杂志,2014,16(2):159-162. 被引量：14
3沈艳军,毕会民.亚临床甲状腺功能减退与糖尿病慢性并发症相关性研究[J].中华老年医学杂志,2012,31(4):294-298. 被引量：30
4沈莉,胡恒贵,秦淑国.促甲状腺激素和甲状腺自身抗体在甲状腺疾病诊断中的临床应用[J].检验医学与临床,2012,9(23):2968-2969. 被引量：16
5仁晖,陈红,宋俊贤,李忠佑,张静,曹成富.65岁以上老年患者血脂水平及达标率随年龄变化的趋势[J].中华老年心脑血管病杂志,2015,17(7):693-696. 被引量：23
6叶文春,方向明,王玉容,高莉,黄婧.亚临床甲状腺功能减退症患者促甲状腺素水平与血脂的关系研究[J].华西医学,2015,30(5):846-849. 被引量：18

二级参考文献57

1张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量：39
2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量：5222
3Ghoraishian SM, Hekmati Moghaddam SH, Afkhami- Ardekani M. Relationship between anti-thyroid peroxidase antibody and thyroid function test[J]. Iran J Immunol,2011,3(3) : 146-149.
4Eckstein A, Mann K,Kahaly GJ,et al. Role of TSH receptor autoantibodies for the diagnosis of Graves disease and for the prediction of the course of hyperthyroidism and ophthalmopathy[J]. Med Klin (Munich), 2009, 104 (5) :343-346.
5Laurberg P,Wallin G,Tallsted L, et al. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine : a 5-year prospective randomized study[J]. Eur J Endocrinol, 2008,158( 1 ): 69-73.
6Karanikas G, Schuetz M,Wahl K, et al. Relation of antiTPO autoantibody titre and T-lymphocyte cytokine production patterns in nashimoto's thyroidities[J]. Clin Endocrinol(Oxf) ,2005,63(2) : 191-196.
7宋武战,池君,汪静.促甲状腺激素受体抗体(TRAb)测定的临床价值[J].放射免疫学杂志,2007,20(5):399-401. 被引量：33
8Gharib H, Turtle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: A joint statement on management from the american association of clinical endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract, 2004,10:497- 501.
9Hoogendoorn EH, Hermus AR, de Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: Influences of age and sex. Clin Chem, 2006,52 : 104-111.
10Hollowell JG, Staehling NW, F|anders WD, et al. Serum TSH, T (4), and thyroid antibodies in the united states population ( 1988 to 1994 ) : National Health and Nutrition Examination Survey ( NHANES ]I ). JClin Endocrinol Metab, 2002,87:489-499.